QPER Health

Cover Block

Name	QPER Health
Tagline	A digital health startup offering a personal health management app and connected device for quantitatively personalized solutions.
Headquarters	Boston, United States
Founded	2019
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry	Healthtech
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder

Links

• Website: https://qper.health/
• LinkedIn: https://www.linkedin.com/company/doxhealth

What an Investor Needs First

QPER Health is a pre-launch digital health startup building a direct-to-consumer subscription business around a quantified, device-driven approach to personal health management. The company, operated by Dox Health, Inc., was founded in 2019 by Rajiv P. Shrestha, a PhD researcher with a background in pharmacy and health services [Tracxn, 2026] [ResearchGate, retrieved 2026]. Its core product is a combined app and connected device ecosystem, requiring users to purchase a blood glucose monitor, blood pressure monitor, and scale, which feeds data into a platform designed to model cardiometabolic health over 26-week cycles [QPER Health App Store, retrieved 2026] [DOX Health, Inc., retrieved 2026]. Differentiation is claimed through a "quantitatively personalized" methodology and a patented Health Map [QPER Health, 2024]. The business model is purely DTC, relying on a pre-registration waitlist with a refundable $1 fee that converts to a subscription and one-time device charge at launch [QPER Health, 2024-2025]. Over the next 12-18 months, the critical watchpoints are the commercial launch and initial user retention metrics, validation of the clinical utility of its health model, and any shift toward enterprise or payer partnerships.

Data Accuracy: YELLOW -- Core product and business model claims are confirmed by the company's own sites; founding date and team size are corroborated by one or two secondary sources (Tracxn, RocketReach). No independent validation of funding, technology, or market traction.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry / Vertical	Healthtech
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder

Inside the Company

QPER Health operates as a digital health startup focused on personal health management, with its public presence tied to Dox Health, Inc., a small corporate entity based in Boston. The company was founded in 2019 by Rajiv P. Shrestha, a pharmaceutical health service researcher and pharmacist by background [Tracxn, 2026] [ResearchGate, retrieved 2026]. Public records describe Dox Health, Inc. as a company with four employees [RocketReach, retrieved 2026] [Wellfound, retrieved 2024].

The company introduced the QPER Health brand publicly in 2024 via a blog post announcing its mission to transform personal health management [QPER Health Blog, 2024]. That same year, the company launched a pre-registration website where consumers can sign up for early access to the forthcoming QPER Health app and device by paying a refundable $1 fee [QPER Health main site, 2024-2025].

Data Accuracy: YELLOW -- Founding year and founder background are corroborated by one source each; team size and entity details are reported by employment data platforms but lack independent verification from major business registries.

Under the Hood

The product is a direct-to-consumer health management system, currently in a pre-launch phase that centers on a waitlist and a connected device bundle. According to the company's website, the user journey begins with a pre-registration that includes a refundable $1.00 fee [QPER Health, 2024-2025]. Upon launch, users are charged a first subscription fee and a one-time device fee before gaining access to the QPER Health app [QPER Health, 2024-2025].

The core technology, as described by the operating entity Dox Health, Inc., is built around a clear input-output model of health, tracking how key cardiometabolic outputs respond over time [DOX Health, Inc. main site, retrieved 2026]. The platform incorporates a patented Health Map and includes tracking for steps, sleep, movement, and nutrition [DOX Health, Inc. main site, retrieved 2026]. The required connected devices, a blood glucose monitor, a blood pressure monitor, and a weighing scale, are listed for sale on the company's website [QPER Health App Store, retrieved 2026]. The company's public language emphasizes "quantitatively personalized solutions" [QPER Health, 2024].

Data Accuracy: YELLOW -- Product details are sourced from the company's own websites and app store listing; no independent reviews or user testimonials are available.

Market Research

The market for consumer-driven health technology is expanding, driven by a confluence of rising healthcare costs, greater personal data ownership, and a post-pandemic focus on preventative care. For QPER Health, which positions itself at the intersection of connected devices, data aggregation, and personalized insights, the relevant market is a subset of the broader digital health and wellness monitoring landscape.

Metric	Value
Wearable Health Devices (Global) 2023	$20B
Projected CAGR 2024-2030	15%

Data Accuracy: YELLOW -- Market sizing is based on an analogous, publicly reported segment; specific TAM for QPER's niche is not confirmed.

Competition and Substitutes

QPER Health enters a crowded market for digital health tools with a pre-launch, direct-to-consumer offering centered on a connected device and a quantitative health map. QPER Health's direct-to-consumer subscription and device fee model places it in the crowded consumer wellness app segment, competing for user attention and wallet share against mass-market platforms like Fitbit and Apple Health. Adjacent to these are specialized digital therapeutics and chronic condition management platforms, such as Omada Health for diabetes or Livongo (now part of Teladoc), which often operate through employer or payer contracts.

Where QPER Health claims a defensible edge today is in its specific framing of "quantitatively personalized" health via a proprietary Health Map, a concept detailed on the DOX Health site [DOX Health, Inc. main site, retrieved 2026]. This intellectual property, coupled with a requirement for specific medical devices (glucose monitor, blood pressure monitor, scale) [QPER Health App Store, retrieved 2026], suggests an attempt to build a more clinically rigorous data foundation than general wellness apps. However, this edge is perishable. It depends entirely on successful product launch and user adoption to generate the proprietary longitudinal data required to validate and improve the Health Map algorithm.

Data Accuracy: YELLOW -- Competitive context is inferred from market observation; specific competitor claims and comparisons are not sourced from direct company disclosures.

Opportunity

The prize for QPER Health is a direct-to-consumer health management platform that captures recurring revenue from a large, engaged user base by becoming a trusted, data-driven partner for lifelong health decisions. The platform's core proposition, as described on its own site, is to help users "take control of their lifelong health journey, 26 weeks at a time" [QPER Health, About us].

Scenario	What happens	Catalyst	Why it's plausible
DTC Subscription Scale	The app and device bundle achieves viral adoption among health-conscious consumers, converting pre-registrants into long-term subscribers.	A successful public launch and positive user reviews drive organic word-of-mouth and app store visibility.	The pre-registration model and refundable fee indicate an existing waitlist-building strategy focused on individual buyers [QPER Health main site, 2024-2025].
Vertical Integration into Chronic Care	The platform evolves from general wellness into a clinically integrated tool for managing specific conditions like prediabetes or hypertension.	Partnerships with telehealth providers or digital pharmacy services to offer QPER as a bundled monitoring solution.	The required device list (blood glucose monitor, blood pressure monitor) aligns directly with chronic condition management [QPER Health App Store, retrieved 2026].
B2B2C Employer Pivot	QPER Health is adopted as a corporate wellness benefit, with employers subsidizing subscriptions for employees.	A pilot deal with a mid-sized employer or a partnership with a benefits administrator.	The focus on quantifiable cardiometabolic outputs creates a value proposition around reducing healthcare costs [DOX Health, Inc. main site, retrieved 2026].

Data Accuracy: YELLOW -- Opportunity analysis is based on company claims and product descriptions; growth scenarios are plausible extrapolations but lack external validation of execution.

Sources

1. [Tracxn, 2026] QPER Health - 2026 Company Profile, Team, Funding & Competitors | https://tracxn.com/d/companies/qperhealth/__rkvBJmIbRnOTlpItk7GcN3smoHykwOCT0OgxDF4tZqM

2. [ResearchGate, retrieved 2026] Rajeev SHRESTHA | PhD Candidate | Bachelor of Pharmacy | Newcastle University, Newcastle upon Tyne | NCL | Research profile | https://www.researchgate.net/profile/Rajeev-Shrestha-2

3. [QPER Health App Store, retrieved 2026] QPER Health App Store listing | https://apps.apple.com/us/app/qper-health/id6738475658

4. [DOX Health, Inc. main site, retrieved 2026] DOX Health, Inc. | https://doxhx.com/

5. [QPER Health, 2024] Introducing QPER Health: Revolutionizing Personal Health Management | https://blog.qper.health/introducing-qper-health/

6. [QPER Health main site, 2024-2025] QPER Health | https://qper.health/

7. [QPER Health, About us] About us - QPER Health | https://qper.health/about-us

8. [RocketReach, retrieved 2026] DOX Health, Inc. Information | https://rocketreach.co/dox-health-inc-management_b78fadf4c255d5c6

9. [Wellfound, retrieved 2024] DOX Health, Inc. profile | https://wellfound.com/company/dox-health-inc

10. [Grand View Research, 2024] Wearable Health Monitoring Devices Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/wearable-health-monitoring-devices-market

11. [Forbes, 2021] Noom Valued At $3.7 Billion After Latest Funding Round | https://www.forbes.com/sites/alexkonrad/2021/05/26/noom-valued-at-37-billion-after-latest-funding-round/